[18F] FAPI-74
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for [18F] FAPI-74, covering 2024-11-29 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients